Moreover, CD40 activation resulted in recruitment of monocytes and T cells into established RCC tumours in vivo where agonistic mAb increased the presence of DC and caused reduction in tumour size17; these effects were immune-mediated, assisted by tumour-cell cytokine secretion and independent of tumour CD40-status. Here, CD40 is linked to renal cell carcinoma.